CLINICAL_TRIALS
trial_result
· 2017-09-05
Clinical Trial Update: Phase I/II - Brentuximab/5-Azacytidine in Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]
Summary
Phase I/II trial of Brentuximab in combination with 5-azacytidine for leukemia was terminated; results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-09-05